<DOC>
	<DOCNO>NCT01845961</DOCNO>
	<brief_summary>The objective proof-of-concept pilot study evaluate galantaminehydrobromide extended-release ( ER ) potential smoking cessation aid treatment-seeking smoker .</brief_summary>
	<brief_title>Effect Galantamine Short-term Abstinence</brief_title>
	<detailed_description>Nicotine dependence major public health problem currently available treatment ineffective majority smoker . Thus , urgent need develop test new medication aid smoke cessation . Recent evidence genetic study prospective smoking cessation conduct CIRNA suggest smoke cessation may influence variationin acetylcholine level . The propose proof-of-concept study randomize , double-blind , placebo-controlled , parallel arm pilot study effect acetylcholinesterase inhibitor , galantamine ( vs. placebo ) , short-term abstinence among 24 treatment-seeking smoker . The primary outcome number day abstinence 7 day quit attempt . Secondary outcome include : smoking rate run-up monitor abstinence phase , medication adherence , side effect , cognitio , smoke urge withdrawal symptons . The pilot data generate used support NIH grant application new investigatot evaluate whether acetylcholinesterase inhibitor could effective smoke cessation medication .</detailed_description>
	<mesh_term>Galantamine</mesh_term>
	<mesh_term>Cholinesterase Inhibitors</mesh_term>
	<criteria>Must age 18 60 Must report smoke least 10 cigarette per day past 6 month Must able provide inform consent Must express interest quit smoke next 2 6 month . Using scale 0 100 , must rate confidence make quit attempt next 6 month 50 high . Exclusion Criteria Smoking Behavior : 1 . Daily use chew tobacco , snuff , and/or snus . 2 . Current enrollment smoking cessation program , use smoke cessation medication last month plan either next month . 3 . Provide carbon monoxide ( CO ) breath sample read less 10 part per million ( ppm ) Intake . Alcohol/Drugs : 1 . History substance abuse past 6 month and/or currently receive treatment substance abuse ( e.g. , alcohol , opioids , cocaine , marijuana , stimulant ) determine selfreport phone screen and/or MINI Intake . Subjects report history substance abuse must remission least 6 month great . 2 . Current alcohol consumption exceed 25 standard drinks/week past 6 month . 3 . Providing breath alcohol concentration ( BrAC ) read great equal 0.01 Intake , Baseline , Testing Days . 4 . A positive urine drug screen cocaine , amphetamine , methamphetamine , benzodiazepine , PCP , methadone , barbiturate , opiate Intake , Baseline , Testing day . Medical : 1 . Women pregnant , plan pregnancy next 3 month , lactate ; female subject shall undergo urine pregnancy test Intake must agree write use approve method contraception . Following enrollment , pregnancy test conduct Baseline Testing day female subject childbearing potential . 2 . Diagnosis Alzheimer 's Disease dementia . 3 . Current treatment cancer diagnose cancer ( except basal cell carcinoma ) past 6 month . 4 . Liver/kidney failure , peptic ulcer disease , benign prostate hypertrophy . 5 . Asthma chronic obstructive pulmonary disease ( COPD ) . 6 . History ( last 6 month ) abnormal heart rhythm , tachycardia and/or cardiovascular disease ( stroke , angina , heart attack ) . These condition evaluate case case basis Study Physician/Health Care Provider . 7 . Serious unstable disease within past 6 month , determine Study Physician/Health Care Provider . 8 . Any impairment ( physical and/or neurological ) include visual impairment prevent cognitive task performance . 9 . Uncontrolled high blood pressure ( SBP &gt; 160 DBP &gt; 100 ) . 10 . Hearing impairment , significant hearing loss ( 20 % either ear ) , cochlear implant , bilateral hearing aid . 11 . History brain injury . 12 . History epilepsy seizure disorder . 13 . Color Blindness . 14 . Low borderline intellectual functioning determine receive score less 90 Shipley Institute Living Scale ( SILS ) correlate Wechsler Adult Intelligence ScaleRevised ( WAISR ) Estimated IQ Test ( administer Intake ) . Psychiatric Exclusion ( determine selfreport phone screen and/or MINI Intake ) : 1 . Current diagnosis major depression . Persons history major depression , remission 6 month longer , eligible , provide exclude base medication ( ) . 2 . Suicide risk score MINI great 0 . 3 . History current diagnosis schizophrenia , psychosis , and/or bipolar disorder . 4 . Current past hypomanic/manic episode . 5 . Current history diagnosis AttentionDeficit/Hyperactivity Disorder ( ADHD ) . Medication : 1 . Current use , recent discontinuation ( within last month ) form smoke cessation medication ( i.e. , Zyban , Wellbutrin , Wellbutrin SR , Chantix , nicotine replacement therapy ) ; 2 . Current use recent discontinuation ( within last 60 day ) : 1 . Antianxiety panic disorder medication . 2 . Antipsychotic medication . 3 . Moodstabilizers ( e.g. , Lithium , Lamictal/lamotrigine , Neurontin/gabapentin , Topamax/topiramate , valproic acid , Tegretol/carbamazepine ) . 4 . Antidepressants ( e.g. , Wellbutrin , MAOIs , SSRIs , tricyclic antidepressant ) . 5 . Prescription stimulant ( e.g. , Provigil , Ritalin , Adderall ) . 6 . Systemic Steroids ( e.g. , Prednisone ) . 7 . Alzheimer 's disease medication ( e.g. , Acetylcholinesterase inhibitor ( ACIs ) , Aricept/donepezil , Exelon/rivastigmine , Tacrine , memantine ) . 8 . Parkinson 's disease medication ( e.g. , Cogentin/benztropine ) . 9 . Irritable bowel syndrome medication ( e.g. , Dicylomine/Bentyl ) . 10 . Heart medication ( e.g. , quinidine Procardia/nifedipine ) . 11 . Peptic ulcer disease medication ( e.g , Zantac/ranitidine ) . 12 . Muscle relaxant ( e.g. , Soma/carisoprodol , Anectine/succinylcholine ) . 13 . Antifungal medication ( e.g. , Nizoral/ketoconazole ) . 14 . Antiseizure medication ( e.g. , Ativan , Banzel , Carbatrol , Dilantin , Lamictal , Gabitril , Lyrica , Neurontin , Tegretol , Topomax ) . 15 . COPD medication ( e.g. , Atrovent/Ipratropium Bromide ) . . 16 . Urinary retention medication ( e.g. , Duvoid/bethanechol , Proscar/finasteride , Avodart/dutasteride , Dibenzyline/phenoxybenzamine , Regitine/phentolamine ) . 17 . Eye medication ( e.g. , Atropine ) . 3 . Daily use : 1 . Opiatecontaining medication chronic pain ( Duragesic/fentanyl patch , Percocet , Oxycontin ) . 2 . Medication asthma ( albuterol , Serevent , Combivent , Advair , Flovent , Azmacort , Symbicort ) . 4 . Known allergy study medication . Current , anticipate , pending enrollment another research program next 23 month could potentially affect subject safety and/or study data/design determine Principal Investigator and/or Study Physician . Not plan live area next two month . No child age 18 , pregnant woman , fetus , neonate , prisoner include research study . Any medical condition , illness , disorder , concomitant medication could compromise participant safety treatment , determine Principal Investigator and/or Study Physician . Inability provide inform consent complete study task determine Principal Investigator . Completion neurocognitive assessment and/or use study medication ( ) CIRNA past 6months could influence performance study task determine Principal Investigator . Not able effectively communicate English ( read , write , speak ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>